Nicholas Bambakidis, MD
- Vice President and Medical Director, Neurological Institute
- Associate Professor
Nicholas C. Bambakidis, MD, is a neurosurgeon at University Hospitals and Director of University Hospitals Neurological Institute. He is Vice Chairman, Clinical Affairs for Neurological Surgery and Professor in the departments of Neurological Surgery and Radiology at Case Western Reserve University School of Medicine as well as Director, Cerebrovascular and Skull Base Surgery, UH Neurological Institute. He sees patients at University Hospitals Cleveland Medical Center and University Hospitals Ahuja Medical Center.
Dr. Bambakidis is board certified in neurological surgery. His special interests include cerebrovascular surgery, cervical spine surgery, endovascular surgery and skull base surgery.
He graduated magna cum laude with a bachelor’s degree in physics from Wright State University, Dayton, Ohio. He earned his medical degree from Case Western Reserve University School of Medicine, where he was inducted into Alpha Omega Alpha Honor Medical Society. Dr. Bambakidis served his neurosurgery residency at UH Cleveland Medical Center, followed by fellowships in spinal neurosurgery and skull base and cerebrovascular surgery at Barrow Neurological Institute, Phoenix.
After completing his fellowships, Dr. Bambakidis served as Assistant Professor of Clinical Neurosurgery at the University of Arizona School of Medicine and an attending neurosurgeon at Barrow Neurological Institute for three years. He came to UH Cleveland Medical Center in 2008 as a fellow in endovascular neurointerventional surgery and was named to the UH staff in 2011.
A dedicated researcher as well as a clinician, Dr. Bambakidis currently is an investigator on several multicenter clinical trials related to advanced neurosurgical techniques and technology and is a co-investigator on the Ohio Brain Tumor Study. He has presented at numerous national and international neurosurgery conferences, speaking on topics such as challenging neurosurgical cases, management of brain tumors, and new skull base surgery techniques.
Dr. Bambakidis has authored or coauthored more than 50 papers and half-a-dozen invited reviews and editorials in peer-reviewed journals, and has contributed chapters to more than a dozen neurosurgical textbooks. He is a reviewer on six leading journals in neurosurgery.
His numerous professional memberships include the Society of Neurointerventional Surgery, Society of Neurological Surgeons, American Association of Neurological Surgeons, and Congress of Neurological Surgeons.
Honors and Achievements
Basic Science Research Award, Ohio State Neurosurgical Association, 2004
Teacher of the Year, Barrow Neurological Institute, Division of Neurosurgery, 2007-2008
Teacher of the Year, St. Joseph’s Hospital and Medical Center, Phoenix, Ariz., 2007-2008
Anspach Research Award in Cerebral Protection/Cerebral Ischemia, 2009 – 2010
Alpha Omega Alpha Honor Medical Society
Cerebrovascular stroke disorders
Brain tumor biology
Skull base surgery
- Brain Trauma Surgery
- Cerebrovascular Surgery
- Cervical Spine Surgery
- Endovascular Surgery
- Skull Base Surgery
- Spinal Cord Tumors
- Spine Surgery
Patient Satisfaction Reviews
4.4 out of 5
- Neurological Surgery - American Board of Neurological Surgery
Fellowship | Neuroradiology/Neurointerventional
Neuroradiology/Neurointerventional - UH Case Medical Center (2009 - 2011)
Fellowship | Cerebrovascular/Skull Base Surgery
Cerebrovascular/Skull Base Surgery - Barrow Neurological Institute (2005 - 2006)
Fellowship | Neurological Surgery - Spinal
Neurological Surgery - Spinal - Barrow Neurological Institute (2004 - 2005)
Residency | Neurological Surgery
Neurological Surgery - University Hospitals Of Cleveland (1998 - 2004)
Internship | General Surgery
General Surgery - University Hospitals Of Cleveland (1997 - 1998)
Case Western Reserve University School Of Medicine (1997)
Wright State University (1993)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Nicholas Bambakidis did not disclose any Outside Relationships with Industry.